GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
70.09
-3.64 (-4.94%)
Nov 15, 2024, 12:13 PM EST - Market open
GeneDx Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Operating Revenue | 263.18 | 195.65 | 227.33 | 205.1 | 175.35 | 191.67 | Upgrade
|
| Other Revenue | 4.05 | 6.91 | 7.36 | 7.1 | 3.97 | 4.51 | Upgrade
|
| Revenue | 267.23 | 202.57 | 234.69 | 212.2 | 179.32 | 196.17 | Upgrade
|
| Revenue Growth (YoY) | 29.41% | -13.69% | 10.60% | 18.33% | -8.59% | 47.12% | Upgrade
|
| Cost of Revenue | 104.59 | 112.42 | 259.52 | 228.8 | 155.73 | 113.39 | Upgrade
|
| Gross Profit | 162.63 | 90.15 | -24.82 | -16.6 | 23.6 | 82.79 | Upgrade
|
| Selling, General & Admin | 165.64 | 194.71 | 338.24 | 324.39 | 173.32 | 78.29 | Upgrade
|
| Research & Development | 46.38 | 58.27 | 86.2 | 105.16 | 72.7 | 34.91 | Upgrade
|
| Other Operating Expenses | 5.27 | 7.22 | 6.31 | - | - | - | Upgrade
|
| Operating Expenses | 217.29 | 260.2 | 430.76 | 429.55 | 246.02 | 113.2 | Upgrade
|
| Operating Income | -54.65 | -170.06 | -455.58 | -446.15 | -222.42 | -30.41 | Upgrade
|
| Interest Expense | -3.31 | - | -0.67 | -2.84 | -2.47 | -0.78 | Upgrade
|
| Interest & Investment Income | - | 1.11 | - | 0.08 | 0.51 | 0.99 | Upgrade
|
| Other Non Operating Income (Expenses) | -21.4 | 1.89 | 60.09 | 198.22 | 0.02 | 0.5 | Upgrade
|
| EBT Excluding Unusual Items | -79.37 | -167.05 | -396.16 | -250.69 | -224.37 | -29.7 | Upgrade
|
| Merger & Restructuring Charges | -0.05 | -0.14 | -1.93 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.95 | - | - | - | - | - | Upgrade
|
| Asset Writedown | - | -10.4 | -210.15 | - | - | - | Upgrade
|
| Other Unusual Items | -1.85 | 0.9 | 10.2 | 5.3 | -16.97 | - | Upgrade
|
| Pretax Income | -84.23 | -176.69 | -598.03 | -245.39 | -241.34 | -29.7 | Upgrade
|
| Income Tax Expense | -0.73 | -0.93 | -49.05 | - | - | - | Upgrade
|
| Net Income | -83.5 | -175.77 | -548.98 | -245.39 | -241.34 | -29.7 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 3.04 | Upgrade
|
| Net Income to Common | -83.5 | -175.77 | -548.98 | -245.39 | -241.34 | -32.74 | Upgrade
|
| Shares Outstanding (Basic) | 26 | 24 | 10 | 3 | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 26 | 24 | 10 | 3 | - | - | Upgrade
|
| Shares Change (YoY) | 27.26% | 137.49% | 212.57% | - | - | - | Upgrade
|
| EPS (Basic) | -3.16 | -7.23 | -53.63 | -74.93 | - | - | Upgrade
|
| EPS (Diluted) | -3.16 | -7.23 | -53.63 | -74.93 | - | - | Upgrade
|
| Free Cash Flow | -59.99 | -185.4 | -326.31 | -199.83 | -117.22 | -30.65 | Upgrade
|
| Free Cash Flow Per Share | -2.27 | -7.63 | -31.88 | -61.02 | - | - | Upgrade
|
| Gross Margin | 60.86% | 44.50% | -10.58% | -7.82% | 13.16% | 42.20% | Upgrade
|
| Operating Margin | -20.45% | -83.95% | -194.12% | -210.25% | -124.04% | -15.50% | Upgrade
|
| Profit Margin | -31.25% | -86.77% | -233.91% | -115.64% | -134.58% | -16.69% | Upgrade
|
| Free Cash Flow Margin | -22.45% | -91.52% | -139.04% | -94.17% | -65.37% | -15.62% | Upgrade
|
| EBITDA | -38.77 | -142.92 | -439.67 | -429.94 | -213.69 | -25.21 | Upgrade
|
| EBITDA Margin | -14.51% | -70.56% | -187.34% | -202.62% | -119.17% | -12.85% | Upgrade
|
| D&A For EBITDA | 15.89 | 27.13 | 15.91 | 16.21 | 8.73 | 5.21 | Upgrade
|
| EBIT | -54.65 | -170.06 | -455.58 | -446.15 | -222.42 | -30.41 | Upgrade
|
| EBIT Margin | -20.45% | -83.95% | -194.12% | -210.25% | -124.04% | -15.50% | Upgrade
|
| Revenue as Reported | 267.23 | 202.57 | 234.69 | 212.2 | 179.32 | 196.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.